Production & Manufacturing

GigaGen Inc., a biotechnology company advancing transformative antibody drugs for infectious diseases, transplant rejection and checkpoint resistant cancers, announced the company has initiated large-scale manufacturing of its first-in-class recombinant hyperimmune drug for COVID-19, GIGA-2050, in collaboration with two partners...

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, announced that it is investing $130 million to add five additional Phase 3 through commercial-scale...

Swiss biotech company Memo Therapeutics AG (MTx), and Northway Biotechpharma (Northway), a leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announce a new partnership to manufacture MTx’s therapeutic COVID-19 antibody candidate in a 4 month fast-track process approved by...

Pfizer Inc. announced a multi-year agreement with Gilead Sciences, Inc. to manufacture and supply Gilead’s investigational antiviral remdesivir, as one of multiple external manufacturing organizations supporting efforts to scale up supply of the investigational treatment for COVID-19. Under the...

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, announced that it was approved by the U.S. FDA to produce commercial drug substance intermediate...

Grand River Aseptic Manufacturing, a leading parenteral contract development and manufacturing organization (CDMO), has been selected by the U.S. Department of Health and Human Services and the U.S. Department of Defense to support the expansion of the United States’...

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing, solutions for drugs, biologics, cell and gene therapies, and consumer health products, announced that it will expand its Argentinian site in Loma Hermosa, Buenos Aires. The expansion,...